|
cervical cancer |
15 |
|
intravoxel incoherent motion |
15 |
|
magnetic resonance imaging |
11 |
|
perfusion |
9 |
|
diffusion magnetic resonance imaging |
8 |
|
diffusion-weighted imaging |
8 |
|
curriculum |
7 |
|
medical students |
7 |
|
chemoradiotherapy |
6 |
|
concurrent chemoradiotherapy |
6 |
|
dce-mri |
6 |
|
ivim |
6 |
|
non-small cell lung cancer |
6 |
|
observer variation |
6 |
|
positron emission tomography |
6 |
|
prognostic factor |
6 |
|
uterine cervical neoplasms |
6 |
|
18f-fdg pet |
5 |
|
18f-fdg pet/ct |
5 |
|
abdominal pregnancy |
5 |
|
aorta |
5 |
|
carcinosarcoma |
5 |
|
contrast-enhanced ct |
5 |
|
ectopic pregnancy |
5 |
|
female |
5 |
|
gestational trophoblastic neoplasia |
5 |
|
head and neck cancer |
5 |
|
hemoperitoneum |
5 |
|
imbalanced datasets |
5 |
|
interval debulking surgery |
5 |
|
leiomyosarcoma |
5 |
|
lymph node metastasis |
5 |
|
neo-adjuvant chemotherapy |
5 |
|
ovarian cancer |
5 |
|
peritoneal carcinomatosis |
5 |
|
pet/ct |
5 |
|
radiomics |
5 |
|
re-sampling techniques |
5 |
|
standardized uptake value |
5 |
|
uterine sarcoma |
5 |
|
acute leukemia |
4 |
|
bone marrow - drug effects - pathology - radionuclide imaging |
4 |
|
extramedullary |
4 |
|
fdg pet/ct |
4 |
|
fluorodeoxyglucose f18 - diagnostic use |
4 |
|
hands-on training |
4 |
|
humans |
4 |
|
ileal neoplasms - drug therapy - pathology - radionuclide imaging |
4 |
|
learning |
4 |
|
male |
4 |
|
myeloid sarcoma |
4 |
|
neoplasm staging |
4 |
|
neoplasm, residual |
4 |
|
ovarian neoplasms |
4 |
|
peritoneal neoplasms |
4 |
|
point-of-care ultrasound |
4 |
|
positron-emission tomography and computed tomography |
4 |
|
positron-emission tomography and computed tomography - methods |
4 |
|
radiopharmaceuticals - diagnostic use |
4 |
|
sarcoma, myeloid - drug therapy - pathology - radionuclide imaging |
4 |
|
sarcoma, myeloid - pathology - radionuclide imaging |
4 |
|
sensitivity and specificity |
4 |
|
teaching |
4 |
|
ultrasonography |
4 |
|
ultrasound |
4 |
|
adenocarcinoma |
3 |
|
area under the curve |
3 |
|
b-values |
3 |
|
cervical carcinoma |
3 |
|
cranial nerves |
3 |
|
diffusion |
3 |
|
diffusion kurtosis imaging |
3 |
|
diffusion-weighted mri |
3 |
|
dwi |
3 |
|
entropy |
3 |
|
figo |
3 |
|
histologic subtypes |
3 |
|
lymphoma |
3 |
|
mantle cell lymphoma |
3 |
|
measurement |
3 |
|
mri |
3 |
|
neurolymphomatosis |
3 |
|
oral arsenic trioxide |
3 |
|
ovarian and peritoneal cancers |
3 |
|
ovarian carcinoma |
3 |
|
refractory |
3 |
|
relapsed |
3 |
|
response criteria |
3 |
|
squamous cell carcinoma |
3 |
|
tumor debulking |
3 |
|
vagus nerve |
3 |
|
contrast media - diagnostic use |
2 |
|
epithelial ovarian carcinoma |
2 |
|
neoplasms - diagnosis - radiography - radionuclide imaging |
2 |
|
nuclear physics medical sciences |
2 |
|
physics |
2 |
|
positron-emission tomography |
2 |
|
radiology and nuclear medicine |
2 |
|
thrombosis - diagnosis - radiography - radionuclide imaging |
2 |
|
x-ray computed tomography |
2 |
|
adolescent |
1 |
|
artifacts |
1 |
|
echo-planar imaging |
1 |
|
endometrial neoplasms |
1 |
|
genital neoplasms |
1 |
|
knee injuries - diagnosis |
1 |
|
pelvis |
1 |
|
references (10) view in table layout |
1 |
|
rupture - diagnosis |
1 |
|
tendon injuries - diagnosis |
1 |
|
uterine cervical neoplasm |
1 |
